Study title: Double-blind studies with mefloquine and in combination with sulfadoxine-pyrimethamine in 120 adults and 120 children with falciparum malaria in Vietnam. Leimer R*,Anh T K,Kim N V,Arnold K,Chien V V,Bich N N,Thoa K,Ladinsky J
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Parasitic Diseases [C03] | |||||
| Brands: Please see report, Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: MEFLOQUINE | |||||
| ATC code: | |||||
| Document link: | |||||
| Document date: | |||||
| Study number: B-0115668 | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | - | |